1. Home
  2. MRVI vs EHAB Comparison

MRVI vs EHAB Comparison

Compare MRVI & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$3.29

Market Cap

472.8M

Sector

Health Care

ML Signal

N/A

Logo Enhabit Inc.

EHAB

Enhabit Inc.

N/A

Current Price

$13.61

Market Cap

690.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRVI
EHAB
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
690.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MRVI
EHAB
Price
$3.29
$13.61
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$4.00
$13.84
AVG Volume (30 Days)
1.2M
2.3M
Earning Date
05-26-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
97.11
EPS
N/A
N/A
Revenue
$185,743,000.00
$1,060,000,000.00
Revenue This Year
$11.80
$6.23
Revenue Next Year
$7.74
$4.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.44
52 Week Low
$1.67
$6.47
52 Week High
$4.11
$13.66

Technical Indicators

Market Signals
Indicator
MRVI
EHAB
Relative Strength Index (RSI) 45.60 79.92
Support Level $3.25 $7.61
Resistance Level $3.99 $13.64
Average True Range (ATR) 0.19 0.03
MACD 0.01 -0.04
Stochastic Oscillator 33.52 59.09

Price Performance

Historical Comparison
MRVI
EHAB

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Share on Social Networks: